AstraZeneca blood cancer drug hits look at aim early

739
0
Dive Brief: A Phase three trial of trying out AstraZeneca’s Sequence in formerly treated chronic lymphocytic leukemia might be stopped early; after a meantime analysis observed sufferers at the blood, ...
Load More